Meridian Bioscience, Inc. (VIVO) – Financial and Strategic SWOT Analysis Review

Meridian Bioscience, Inc. (VIVO) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
60
Medical Devices
United States

Meridian Bioscience, Inc. (VIVO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company that manufactures diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It has over 140 diagnostic tests and transport media, spanning from prenatal care, respiratory infections, and organ transplant infections among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices, and diagnostics manufacturers in over 60 countries the world over. Meridian is headquartered in Ohio, the US.

Meridian seeks to establish development and marketing partnerships, research collaborations, technology in-licensing with other companies which would enhance the company’s capabilities, clinical program and product pipeline. The company focuses on its product portfolio expansion by building strong operating base besides gaining expertise through strategic agreements and collaborations.

Meridian Bioscience, Inc. Key Recent Developments

Jan 22, 2015: Meridian Bioscience Reports First Quarter 2015 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance
Jan 09, 2015: Meridian Opens a New Office in Beijing, China
Nov 07, 2013: Meridian Bioscience Reports Record Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, Announces Increased Regular Cash Dividend Rate for Fiscal 2014, and Reaffirms Fiscal
Oct 31, 2013: Meridian Life Science Awarded SBIR by Centers for Disease Control and Prevention to Develop Rotavirus Vaccine
Jul 25, 2013: Meridian Bioscience Reports Revenue Of $47.1m In Q2 Fiscal 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Meridian Bioscience, Inc. – Key Facts 6
Meridian Bioscience, Inc. – Key Employees 7
Meridian Bioscience, Inc. – Key Employee Biographies 8
Meridian Bioscience, Inc. – Major Products and Services 9
Meridian Bioscience, Inc. – Medical Equipment Pipeline Products Data 13
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 13
Meridian Bioscience, Inc. Pipeline Products by Development Stage 14
Meridian Bioscience, Inc. – History 15
Meridian Bioscience, Inc. – Company Statement 19
Meridian Bioscience, Inc. – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Meridian Bioscience, Inc. – Key Manufacturing Facilities 23
Section 2 – Company Analysis 24
Meridian Bioscience, Inc. – Business Description 24
Meridian Bioscience, Inc. – Corporate Strategy 25
Meridian Bioscience, Inc. – SWOT Analysis 26
SWOT Analysis – Overview 26
Meridian Bioscience, Inc. – Strengths 26
Strength – Established Presence in North America 26
Strength – Strategic Acquisitions 26
Strength – Strong Research and Development Activities 26
Meridian Bioscience, Inc. – Weaknesses 27
Weakness – Reliance on a Few Distributors 27
Weakness – Declining Performance of Diagnostics Division 27
Meridian Bioscience, Inc. – Opportunities 28
Opportunity – Growing IVD Market 28
Opportunity – Growing Market for Infectious Disease Tests 28
Opportunity – Regulatory Approvals and New Product Lauches 28
Meridian Bioscience, Inc. – Threats 29
Threat – Integration of Acquisitions 29
Threat – Government Regulations 29
Threat – Intense Competition 29
Meridian Bioscience, Inc. – Key Competitors 30
Section 3 – Company Financial Ratios 31
Financial Ratios – Capital Market Ratios 31
Financial Ratios – Annual Ratios 32
Performance Chart 34
Financial Performance 34
Financial Ratios – Interim Ratios 35
Financial Ratios – Ratio Charts 36
Section 4 – Company’s Lifesciences Financial Deals and Alliances 37
Meridian Bioscience, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 37
Meridian Bioscience, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 38
Meridian Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 39
Meridian Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 40
Meridian Bioscience, Inc., Recent Deals Summary 41
Section 5 – Company’s Recent Developments 42
Mar 11, 2015: Bioline Launches Latest ISOLATE II miRNA and RNA Purification Kits 42
Feb 26, 2015: Meridian Bioscience Receives CE Marking for Two New Molecular Amplification Tests: illumigene Chlamydia and illumigene Gonorrhea 43
Jan 22, 2015: Meridian Bioscience Reports First Quarter 2015 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance 44
Jan 09, 2015: Meridian Opens a New Office in Beijing, China 46
Nov 06, 2014: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance 47
Sep 03, 2014: Meridian Bioscience Signs Agreement with Premier to Offer Its Hospitals Molecular Diagnostic Tests and Instruments 49
Sep 02, 2014: Meridian Bioscience Provides Net Revenues and Earnings Guidance for Fiscal 2015 and Reaffirms Fiscal 2014 Guidance 50
Jul 24, 2014: Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance 51
Apr 24, 2014: Meridian Bioscience Reports Second Quarter 2014 Operating Results and Revises Fiscal 2014 Guidance 53
Mar 27, 2014: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene Pertussis 55
Section 6 – Appendix 56
Methodology 56
Ratio Definitions 56
About GlobalData 60
Contact Us 60
Disclaimer 60



List of Tables
Meridian Bioscience, Inc., Key Facts 6
Meridian Bioscience, Inc., Key Employees 7
Meridian Bioscience, Inc., Key Employee Biographies 8
Meridian Bioscience, Inc., Major Products and Services 9
Meridian Bioscience, Inc. Number of Pipeline Products by Equipment Type 13
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 13
Meridian Bioscience, Inc. Number of Pipeline Products by Development Stage 14
Meridian Bioscience, Inc. Pipeline Products by Development Stage 14
Meridian Bioscience, Inc., History 15
Meridian Bioscience, Inc., Other Locations 21
Meridian Bioscience, Inc., Subsidiaries 21
Meridian Bioscience, Inc., Key Manufacturing Facilities 23
Meridian Bioscience, Inc., Key Competitors 30
Meridian Bioscience, Inc., Ratios based on current share price 31
Meridian Bioscience, Inc., Annual Ratios 32
Meridian Bioscience, Inc., Interim Ratios 35
Meridian Bioscience, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 37
Meridian Bioscience, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 38
Meridian Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 39
Meridian Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 40
Meridian Bioscience, Inc., Recent Deals Summary 41
Currency Codes 56
Capital Market Ratios 56
Equity Ratios 57
Profitability Ratios 57
Cost Ratios 58
Liquidity Ratios 58
Leverage Ratios 59
Efficiency Ratios 59



List of Figures
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 13
Meridian Bioscience, Inc. Pipeline Products by Development Stage 14
Meridian Bioscience, Inc., Performance Chart (2010 – 2014) 34
Meridian Bioscience, Inc., Ratio Charts 36
Meridian Bioscience, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 37
Meridian Bioscience, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 38
Meridian Bioscience, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 39
Meridian Bioscience, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 40

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.